AustinPx
111 W. Cooperative Way, Bldg. 3
Georgetown, TX 78626
T: (512) 686-4740
E: info@austinpx.com
W: www.austinpx.com
LinkedIn: https://www.linkedin.com/company/2556372/

COMPANY DESCRIPTION

AustinPx was founded to help developers realize the full potential of their drug candidates. There are many obstacles to bringing a drug to market, including poor bioavailability and accelerated timelines. That’s where we come in. Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical, and manufacturing experts work with you to overcome challenges and identify opportunities to do more, faster. As the inventors of KinetiSol™ Technology, a next-generation amorphous solid dispersion (ASD) technology for poorly soluble APIs, with its smaller footprint, broader design space, and greener processing solutions, we aim to disrupt the ASD industry.

SERVICES & CAPABILITIES

Preclinical Development

• Molecule Characterization
• Preformulation Testing
• Formulation Technology Screening- including dry and wet granulations, amorphous dispersions, cyclodextrin complexations, particle size reduction, and lipid-based formulations.

Formulation Development

• Drug Product Intermediate and Finished Dose Development that include solutions, suspensions, tablets, and capsules
• Immediate and Modified Release
• Bioavailability Enhancement Technologies, such as KinetiSol™ for amorphous solid dispersions, spray-drying, hot melt extrusion, and lipid delivery
• API in Capsule or Bottle

Analytical

• Chemical Analysis
• Dissolution/Flux
• Drug Product Test Methods
• Preclinical through Commercial: qualification/validation
• Release Testing and GMP Stability Studies

GMP Manufacturing

• KinetiSol™ Technology
• Blending
• Milling
• Granulation
• Encapsulation
• Tableting
• Packaging- botting and clinical labeling